Retatrutide for Athletes — What You Need to Know About the Next Generation GLP-1
Retatrutide is Eli Lilly's triple receptor GLP-1 drug currently in Phase 3 trials. Here is what athletes and bariatric patients need to know about how it works and when it might be available.